Cetera Advisor Networks’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.73M | Buy |
8,009
+1,689
| +27% | +$396K | 0.01% | 1108 |
|
|
2023
Q4 | $1.64M | Buy |
6,320
+230
| +4% | +$56.5K | 0.01% | 1071 |
|
|
2023
Q3 | $1.57M | Buy |
6,090
+374
| +7% | +$100K | 0.01% | 1020 |
|
|
2023
Q2 | $1.63M | Buy |
5,716
+438
| +8% | +$130K | 0.01% | 959 |
|
|
2023
Q1 | $1.47M | Buy |
5,278
+1,030
| +24% | +$285K | 0.01% | 1002 |
|
|
2022
Q4 | $1.18M | Buy |
4,248
+2,063
| +94% | +$583K | 0.01% | 1096 |
|
|
2022
Q3 | $583K | Buy |
2,185
+146
| +7% | +$31K | 0.01% | 1183 |
|
|
2022
Q2 | $415K | Buy |
2,039
+225
| +12% | +$46K | 0.01% | 1397 |
|
|
2022
Q1 | $382K | Sell |
1,814
-8
| -0.4% | -$1.74K | ﹤0.01% | 1480 |
|
|
2021
Q4 | $437K | Sell |
1,822
-1,413
| -44% | -$363K | 0.01% | 1354 |
|
|
2021
Q3 | $915K | Buy |
3,235
+126
| +4% | +$41.3K | 0.01% | 887 |
|
|
2021
Q2 | $1.08M | Buy |
3,109
+1,323
| +74% | +$401K | 0.02% | 800 |
|
|
2021
Q1 | $500K | Buy |
1,786
+68
| +4% | +$18.3K | 0.01% | 874 |
|
|
2020
Q4 | $421K | Buy |
1,718
+42
| +3% | +$10.8K | 0.01% | 864 |
|
|
2020
Q3 | $475K | Sell |
1,676
-148
| -8% | -$41.3K | 0.01% | 727 |
|
|
2020
Q2 | $488K | Sell |
1,824
-155
| -8% | -$46.6K | 0.01% | 703 |
|
|
2020
Q1 | $626K | Sell |
1,979
-140
| -7% | -$42.5K | 0.02% | 544 |
|
|
2019
Q4 | $629K | Buy |
2,119
+266
| +14% | +$73.8K | 0.02% | 651 |
|
|
2019
Q3 | $430K | Sell |
1,853
-509
| -22% | -$119K | 0.01% | 756 |
|
|
2019
Q2 | $551K | Sell |
2,362
-714
| -23% | -$165K | 0.02% | 644 |
|
|
2019
Q1 | $727K | Buy |
3,076
+182
| +6% | +$57.3K | 0.02% | 541 |
|
|
2018
Q4 | $873K | Buy |
2,894
+701
| +32% | +$224K | 0.03% | 406 |
|
|
2018
Q3 | $775K | Buy |
2,193
+113
| +5% | +$38.9K | 0.03% | 494 |
|
|
2018
Q2 | $605K | Sell |
2,080
-1,179
| -36% | -$331K | 0.03% | 423 |
|
|
2018
Q1 | $895K | Sell |
3,259
-228
| -7% | -$70.8K | 0.04% | 350 |
|
|
2017
Q4 | $1.11M | Buy |
3,487
+852
| +32% | +$273K | 0.05% | 333 |
|
|
2017
Q3 | $826K | Buy |
2,635
+237
| +10% | +$70.2K | 0.04% | 385 |
|
|
2017
Q2 | $651K | Sell |
2,398
-160
| -6% | -$42.3K | 0.03% | 442 |
|
|
2017
Q1 | $703K | Buy |
2,558
+144
| +6% | +$40.7K | 0.03% | 404 |
|
|
2016
Q4 | $686K | Sell |
2,414
-659
| -21% | -$195K | 0.04% | 387 |
|
|
2016
Q3 | $962K | Buy |
3,073
+220
| +8% | +$65.2K | 0.04% | 387 |
|
|
2016
Q2 | $689K | Sell |
2,853
-247
| -8% | -$65.1K | 0.04% | 361 |
|
|
2016
Q1 | $810K | Buy |
3,100
+172
| +6% | +$45.4K | 0.05% | 328 |
|
|
2015
Q4 | $897K | Buy |
2,928
+669
| +30% | +$192K | 0.06% | 296 |
|
|
2015
Q3 | $659K | Sell |
2,259
-467
| -17% | -$154K | 0.05% | 353 |
|
|
2015
Q2 | $1.15M | Hold |
2,726
| – | – | 0.07% | 260 |
|
|
2015
Q1 | $1.15M | Sell |
2,726
-1,212
| -31% | -$478K | 0.07% | 261 |
|
|
2014
Q4 | $1.33M | Buy |
3,938
+541
| +16% | +$175K | 0.09% | 218 |
|
|
2014
Q3 | $1.12M | Buy |
3,397
+811
| +31% | +$267K | 0.08% | 253 |
|
|
2014
Q2 | $820K | Buy |
2,586
+26
| +1% | +$7.83K | 0.05% | 342 |
|
|
2014
Q1 | $785K | Buy |
2,560
+146
| +6% | +$46.3K | 0.06% | 329 |
|
|
2013
Q4 | $674K | Sell |
2,414
-100
| -4% | -$25.9K | 0.05% | 346 |
|
|
2013
Q3 | $604K | Buy |
2,514
+325
| +15% | +$72.7K | 0.05% | 322 |
|
|
2013
Q2 | $472K | Buy |
+2,189
| New | +$468K | 0.05% | 326 |
|
Other funds holding BIIB
Cetera Advisor Networks's BIIB Position: Q1 2024 in Review
Cetera Advisor Networks increased its Biogen (BIIB) stake by 27% in Q1 2024, buying an estimated $396K and bringing the position to 8,009 shares worth $1.73M. The position accounts for 0.01% of the portfolio, ranked #1108.
Cetera Advisor Networks first reported a position in BIIB in Q2 2013 and has held it in 44 quarters since. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.
- Cetera Advisor Networks held 8,009 shares of Biogen worth $1.73M as of Q1 2024.
- Cetera Advisor Networks bought 1,689 Biogen shares in Q1 2024, an estimated $396K.
- Biogen made up 0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1108 holding.
- Cetera Advisor Networks first reported a position in Biogen in Q2 2013 and has held it in 44 quarters since.
- 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.
Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.